Louis Schmukler
Corporate Officer/Principal bei BRISTOL-MYERS SQUIBB COMPANY
Profil
Derzeit ist Louis S. Schmukler President-Global Product Development & Supply bei Bristol Myers Squibb Co. Er ist außerdem Mitglied der National Association of Manufacturers, Mitglied der Pharmaceutical Research & Manufacturers of America, Mitglied der International Society for Pharmaceutical Engineering und Mitglied der Biophorum Operations Group Ltd. Zuvor war er Senior VP-Pharmaceutical Operating Unit bei Wyeth Corp., Principal bei Sandoz, Inc. und Vice President-Quality bei Hoffmann-La Roche, Inc. sowie Principal bei Marion Merrell Dow, Inc. Louis S. Schmukler erwarb einen Bachelor-Abschluss an der Temple University (Pennsylvania) und einen Master-Abschluss an der Webster University.
Aktive Positionen von Louis Schmukler
Unternehmen | Position | Beginn |
---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 24.12.2012 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Corporate Officer/Principal | - |
International Society for Pharmaceutical Engineering
International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Corporate Officer/Principal | - |
Biophorum Operations Group Ltd.
Biophorum Operations Group Ltd. Miscellaneous Commercial ServicesCommercial Services Biophorum Operations Group Ltd. engages in the manufacture and supply of biopharmaceutical products. It offers cell and gene therapy, drug substance, technology road mapping, and regulatory interaction. The company was founded on January 19, 2009 and is headquartered in Sheffield, the United Kingdom. | Corporate Officer/Principal | - |
National Association of Manufacturers
National Association of Manufacturers Miscellaneous Commercial ServicesCommercial Services The National Association of Manufacturers is an organization that works for the success of over 12.9 million people who are involved in manufacturing. The non-profit company is based in Washington and has subsidiaries in the United States. The American company's work is based on four core values that drive the industry. The company commissioned a study in August 2015, which found that the EPA's proposed ozone rule could reduce GDP by $140 billion. The CEO of the company is Jay Timmons. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Louis Schmukler
Unternehmen | Position | Ende |
---|---|---|
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | - |
Marion Merrell Dow, Inc. | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - |
Ausbildung von Louis Schmukler
Temple University (Pennsylvania) | Undergraduate Degree |
Webster University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Private Unternehmen | 8 |
---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Marion Merrell Dow, Inc. | Health Technology |
National Association of Manufacturers
National Association of Manufacturers Miscellaneous Commercial ServicesCommercial Services The National Association of Manufacturers is an organization that works for the success of over 12.9 million people who are involved in manufacturing. The non-profit company is based in Washington and has subsidiaries in the United States. The American company's work is based on four core values that drive the industry. The company commissioned a study in August 2015, which found that the EPA's proposed ozone rule could reduce GDP by $140 billion. The CEO of the company is Jay Timmons. | Commercial Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
International Society for Pharmaceutical Engineering
International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Commercial Services |
Biophorum Operations Group Ltd.
Biophorum Operations Group Ltd. Miscellaneous Commercial ServicesCommercial Services Biophorum Operations Group Ltd. engages in the manufacture and supply of biopharmaceutical products. It offers cell and gene therapy, drug substance, technology road mapping, and regulatory interaction. The company was founded on January 19, 2009 and is headquartered in Sheffield, the United Kingdom. | Commercial Services |